Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Newell

Showing results (301-310 of 357) with videos related to

Pageof 36
Sort By:
Blood|March 31, 2025
Hallmarks of terminal T-cell exhaustion are absent in multiple myeloma from diagnosis through maintenance therapyCarolyn Shasha, David R Glass, Ernest Moelhman, et al.
Plos Pathogens|May 17, 2023
Distinct immune responses associated with vaccination status and protection outcomes after malaria challengeDamian A Oyong, Fergal J Duffy, Maxwell L Neal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 11, 2021
Intratumoral CD39<sup>+</sup>CD8<sup>+</sup> T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLCJoe Yeong, Lisda Suteja, Yannick Simoni, et al.
Nature Immunology|June 20, 2019
Plasmacytoid dendritic cells develop from Ly6D<sup>+</sup> lymphoid progenitors distinct from the myeloid lineageRegine J Dress, Charles-Antoine Dutertre, Amir Giladi, et al.
Cell Reports. Medicine|February 10, 2024
Circulating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinomaThomas Pulliam, Saumya Jani, Lichen Jing, et al.
Mucosal Immunology|July 30, 2015
CD161(int)CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gutJ R Fergusson, M H Hühn, L Swadling, et al.
Nature Cancer|March 1, 2024
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocolsOren Barboy, Akhiad Bercovich, Hanjie Li, et al.
Gastroenterology|April 18, 2020
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infectionNina Le Bert, Upkar S Gill, Michelle Hong, et al.
Ebiomedicine|November 14, 2025
Unbiased cell clustering analysis of vaccine-induced T cell responses in the Imbokodo HIV-1 vaccine trialValentin Voillet, Janine van Duijn, Kanika Vanshylla, et al.
Science Immunology|July 15, 2017
Host sirtuin 1 regulates mycobacterial immunopathogenesis and represents a therapeutic target against tuberculosisCatherine Y Cheng, Nuria M Gutierrez, Mardiana B Marzuki, et al.
Pageof 36

Showing results (301-310 of 357) with videos related to

Sort By:
Pageof 36
Blood|March 31, 2025
Hallmarks of terminal T-cell exhaustion are absent in multiple myeloma from diagnosis through maintenance therapyCarolyn Shasha, David R Glass, Ernest Moelhman, et al.
Plos Pathogens|May 17, 2023
Distinct immune responses associated with vaccination status and protection outcomes after malaria challengeDamian A Oyong, Fergal J Duffy, Maxwell L Neal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 11, 2021
Intratumoral CD39<sup>+</sup>CD8<sup>+</sup> T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLCJoe Yeong, Lisda Suteja, Yannick Simoni, et al.
Nature Immunology|June 20, 2019
Plasmacytoid dendritic cells develop from Ly6D<sup>+</sup> lymphoid progenitors distinct from the myeloid lineageRegine J Dress, Charles-Antoine Dutertre, Amir Giladi, et al.
Cell Reports. Medicine|February 10, 2024
Circulating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinomaThomas Pulliam, Saumya Jani, Lichen Jing, et al.
Mucosal Immunology|July 30, 2015
CD161(int)CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gutJ R Fergusson, M H Hühn, L Swadling, et al.
Nature Cancer|March 1, 2024
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocolsOren Barboy, Akhiad Bercovich, Hanjie Li, et al.
Gastroenterology|April 18, 2020
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infectionNina Le Bert, Upkar S Gill, Michelle Hong, et al.
Ebiomedicine|November 14, 2025
Unbiased cell clustering analysis of vaccine-induced T cell responses in the Imbokodo HIV-1 vaccine trialValentin Voillet, Janine van Duijn, Kanika Vanshylla, et al.
Science Immunology|July 15, 2017
Host sirtuin 1 regulates mycobacterial immunopathogenesis and represents a therapeutic target against tuberculosisCatherine Y Cheng, Nuria M Gutierrez, Mardiana B Marzuki, et al.
Pageof 36